BioCardia receives FDA confirmation for CardiAMP trial pathway

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/12/2026

1. ORCL
2. SPY
3. SPCX
4. USO
5. CHWY
6. NAVN
7. CRWV
8. CME
9. HUMA
10. NVDA

Go back to BioCardia receives FDA confirmation for CardiAMP trial pathway
(NASDAQ: BCDA) Delayed: 0.80 +0.31 (63.27%)
Previous Close $0.49    52 Week High $0.17 
Open $0.48    52 Week Low $0.12 
Day High $0.85    P/E N/A 
Day Low $0.78    EPS $0.00 
Volume 803,531